The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Roflumilast promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]]; RAPGEF3 mutant form inhibits the reaction [Roflumilast results in increased phosphorylation of AKT1 protein]; Roflumilast promotes the reaction [Nitroprusside results in increased phosphorylation of AKT1 protein]
Roflumilast inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of AQP1 protein]
Roflumilast inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of AQP5 mRNA]; Roflumilast inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of AQP5 protein]
Roflumilast inhibits the reaction [Cisplatin results in increased expression of BAX mRNA]; Roflumilast inhibits the reaction [Cisplatin results in increased expression of BAX protein] [Cisplatin co-treated with Roflumilast] results in increased expression of BAX mRNA; Cisplatin promotes the reaction [Roflumilast results in increased expression of BAX mRNA]; Cisplatin promotes the reaction [Roflumilast results in increased expression of BAX protein]; Roflumilast promotes the reaction [Cisplatin results in increased expression of BAX protein] Roflumilast results in increased expression of BAX mRNA; Roflumilast results in increased expression of BAX protein
Cisplatin promotes the reaction [Roflumilast results in decreased expression of BCL2 mRNA]; Cisplatin promotes the reaction [Roflumilast results in decreased expression of BCL2 protein]; Roflumilast promotes the reaction [Cisplatin results in decreased expression of BCL2 mRNA]; Roflumilast promotes the reaction [Cisplatin results in decreased expression of BCL2 protein] Roflumilast results in decreased expression of BCL2 mRNA; Roflumilast results in decreased expression of BCL2 protein Roflumilast inhibits the reaction [Cisplatin results in decreased expression of BCL2 mRNA]; Roflumilast inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]
Roflumilast results in increased expression of CASP3 mRNA Roflumilast results in decreased expression of CASP3 protein Roflumilast results in increased activity of CASP3 protein Roflumilast inhibits the reaction [Cisplatin results in increased activity of CASP3 protein]; Roflumilast inhibits the reaction [Cisplatin results in increased expression of CASP3 mRNA]; Roflumilast inhibits the reaction [Rotenone results in increased expression of CASP3 protein] [Cisplatin co-treated with Roflumilast] results in increased expression of CASP3 mRNA; Cisplatin promotes the reaction [Roflumilast results in increased activity of CASP3 protein]; Cisplatin promotes the reaction [Roflumilast results in increased expression of CASP3 mRNA]; Roflumilast promotes the reaction [Cisplatin results in increased activity of CASP3 protein]
Roflumilast inhibits the reaction [Cisplatin results in decreased activity of CAT protein]; Roflumilast inhibits the reaction [Rotenone results in decreased activity of CAT protein]
Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]]; Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]; Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]]; Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL2 protein]
Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]]; Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]; Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]]; Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL3 protein]
Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL4 protein]]]; Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL4 protein]]; Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL4 protein]]; Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CCL4 protein]
Roflumilast inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of CFTR mRNA]; Roflumilast inhibits the reaction [[Vehicle Emissions results in increased abundance of Particulate Matter] which results in decreased expression of CFTR protein]
Roflumilast inhibits the reaction [Hypochlorous Acid results in increased expression of COL1A1 mRNA]; Roflumilast inhibits the reaction [Hypochlorous Acid results in increased expression of COL1A1 protein] Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Roflumilast promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein]]; Roflumilast inhibits the reaction [Rotenone results in decreased phosphorylation of CREB1 protein]; Roflumilast promotes the reaction [Nitroprusside results in increased phosphorylation of CREB1 protein] Roflumilast results in increased phosphorylation of CREB1 protein
Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]]]; Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]]; Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]]; Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]
Roflumilast inhibits the reaction [Hypochlorous Acid results in increased expression of FN1 protein] Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]
Cisplatin promotes the reaction [Roflumilast results in increased expression of HMOX1 mRNA]; Roflumilast promotes the reaction [Cisplatin results in increased expression of HMOX1 mRNA] Roflumilast inhibits the reaction [Rotenone results in decreased expression of HMOX1 protein]; Roflumilast promotes the reaction [Cisplatin results in increased activity of HMOX1 protein]; Roflumilast promotes the reaction [Cisplatin results in increased expression of HMOX1 mRNA]
KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]]; Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]; sanguinarine inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]] Roflumilast inhibits the reaction [Hypochlorous Acid results in increased phosphorylation of MAPK1 protein]
Roflumilast inhibits the reaction [Hypochlorous Acid results in increased phosphorylation of MAPK3 protein] KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]]; Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]; sanguinarine inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]]
[Roflumilast co-treated with Rotenone] results in increased expression of and results in increased localization of NFE2L2 protein; Roflumilast promotes the reaction [Cisplatin results in increased expression of NFE2L2 mRNA] Roflumilast results in increased expression of NFE2L2 mRNA Cisplatin promotes the reaction [Roflumilast results in increased expression of NFE2L2 mRNA]; Roflumilast promotes the reaction [Cisplatin results in increased expression of NFE2L2 mRNA]
Cisplatin promotes the reaction [Roflumilast results in increased expression of NQO1 mRNA]; Roflumilast promotes the reaction [Cisplatin results in increased expression of NQO1 mRNA]
Roflumilast results in decreased activity of PDE4B protein Roflumilast inhibits the reaction [Hypochlorous Acid results in increased expression of PDE4B protein alternative form] Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of PDE4B protein alternative form]
RAPGEF3 mutant form inhibits the reaction [Roflumilast results in increased phosphorylation of AKT1 protein] Roflumilast results in increased expression of RAPGEF3 protein
Roflumilast inhibits the reaction [Cisplatin results in increased expression of RELA mRNA]; Roflumilast inhibits the reaction [Rotenone results in increased expression of RELA protein] Roflumilast results in decreased expression of RELA mRNA Cisplatin promotes the reaction [Roflumilast results in decreased expression of RELA mRNA]
Roflumilast inhibits the reaction [Hypochlorous Acid results in increased phosphorylation of SMAD3 protein] KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]]; Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]; sanguinarine inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]]
Roflumilast inhibits the reaction [Rotenone results in increased expression of SNCA protein] Roflumilast results in increased degradation of SNCA protein
KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]]; KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]]; KT 5720 inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]]; Roflumilast inhibits the reaction [TGFB1 protein results in decreased expression of PPM1A protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased activity of GLB1 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of CCN2 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of CDKN1A protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of CNN1 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of FAP protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of FN1 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of NOX4 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of PDE4B protein alternative form]; Roflumilast inhibits the reaction [TGFB1 protein results in increased expression of SERPINE1 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]; Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]; sanguinarine inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]]; sanguinarine inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein]]; sanguinarine inhibits the reaction [Roflumilast inhibits the reaction [TGFB1 protein results in increased phosphorylation of SMAD3 protein]] Roflumilast inhibits the reaction [Hypochlorous Acid results in increased expression of TGFB1 mRNA]
Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]]; Dinoprostone promotes the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]; Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] Roflumilast inhibits the reaction [Cisplatin results in increased expression of TNF protein]; Roflumilast inhibits the reaction [Rotenone results in increased expression of TNF protein]